The GSA Cure Accelerator Grant supports high-impact research with the potential to meaningfully improve the lives of individuals with Gorlin syndrome and accelerate progress toward prevention, better treatments, and ultimately, a cure. Guided by the GSA Research Roadmap, this annual award funds milestone-driven projects that address critical gaps in our understanding of the disease and advance promising discoveries toward clinical impact.
The GSA welcomes proposals spanning basic, translational, clinical, computational, and patient-centered research. Projects focused on therapeutic development, disease prevention, biomarker discovery, natural history, clinical trial readiness, precision medicine, and other innovative approaches are encouraged.
Grant Details:
Award: Up to $100,000
Project Period: One year
Application Cycle: Fall (Applications due October 1)
Ready to apply?
Download the current Request for Applications (RFA) for eligibility requirements, application instructions, and review criteria.
Recipient institutions will be required to execute GSA's standard Award Agreement before grant funds are released. The Award Agreement is available upon request prior to application submission.
%20(2).png?width=150&height=64&name=GSA%20Logo%20High%20Res%20No%20Background%20(1)%20(2).png)
%20(2)-1.png?width=200&height=85&name=GSA%20Logo%20High%20Res%20No%20Background%20(1)%20(2)-1.png)